Yarbrough Capital, LLC
- SEC CIK
- 0001767686
- Latest filing
- Aug 10, 2026
NAMS holding history
NewAmsterdam Pharma Co N.V. in every 13F filed by Yarbrough Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAMS overviewAll 13F holders of NAMSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −23,960−100.0% | Sold out | Holders |
| Q4 2025 | 23,960 | $840.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 23,960 | $681.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 23,960 | $433.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 23,960 | $490.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 23,960 | $615.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 23,960 | $397.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 23,960 | $460.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 23,960 | $566.7K | <0.1% | +23,960 | New | Holders |